Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Search content at Mayo Clinic
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Galectin-4 expression in carcinoid tumors
Kandelaria M. Rumilla
, Lori A. Erickson
, Alan K. Erickson
, Ricardo V. Lloyd
Laboratory Medicine and Pathology
Research output
:
Contribution to journal
›
Article
›
peer-review
20
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Galectin-4 expression in carcinoid tumors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Carcinoid Tumor
100%
Galectin-4
100%
Ileal Carcinoids
63%
Galectin-1 (Gal-1)
54%
Galectin-3 (Gal-3)
45%
Lung
18%
Western Blot
18%
Pancreatic Neuroendocrine Tumors (pNETs)
18%
Enterochromaffin Cells
9%
Gastrointestinal Tract
9%
Expression Level
9%
Cell Adhesion
9%
Western Blotting
9%
Immunohistochemistry
9%
Metastatic Tumor
9%
Monoclonal Antibody
9%
Tumor Metastasis
9%
Tumor Progression
9%
Tissue Microarray
9%
Stomach
9%
Small Intestine
9%
Porcine
9%
Neoplastic Cells
9%
Rectum
9%
Evolutionarily Conserved
9%
Pulmonary Carcinoid
9%
Carbohydrate-binding Protein
9%
Carcinoid
9%
Inflammation Cells
9%
Lectin
9%
Rectal Tumor
9%
Gastric Carcinoid
9%
Metastatic Carcinoid
9%
Primary Pulmonary Tumor
9%
Rectal Carcinoid
9%
Differential Distribution
9%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinoid
100%
Galectin 4
100%
Galectin 3
35%
Galectin 1
35%
Western Blot
21%
Pancreas Islet Cell Tumor
14%
Inflammation
7%
Monoclonal Antibody
7%
Tumor Growth
7%
Lung Tumor
7%
Carbohydrate Binding Protein
7%
Lectin
7%
Rectum Tumor
7%
Galectin
7%